CRISPR-mediated phage resistance in Streptococcus thermophilus is a novel defense mechanism that allows bacteria to acquire resistance against bacteriophages. This system involves the integration of short stretches of phage-derived sequences (spacers) into CRISPR loci, which are then used to recognize and neutralize phage infections. In this study, researchers characterized the efficiency of CRISPR1 as a phage resistance mechanism in S. thermophilus. They found that CRISPR1 is distinct from previously known phage defense systems and is effective against the two main groups of S. thermophilus phages. The addition of new spacers in CRISPR1 increases the overall phage resistance of the host. The new spacers are typically 29 to 31 nucleotides long, with 30 being the most common. Comparative analysis of these spacers with the genomes of wild-type phages showed that the newly added spacer must be identical to a region (named proto-spacer) in the phage genome to confer resistance. Additionally, a specific sequence (NNAGAAW) located downstream of the proto-spacer region is important for the phage resistance phenotype. The study also showed that virulent phages rapidly evolve through single nucleotide mutations or deletions in response to CRISPR1. S. thermophilus is an important industrial lactic acid bacterium used in dairy production, but its use has been hindered by the presence of virulent phages. The study highlights the role of CRISPR1 in phage-host interactions and demonstrates that iterative addition of spacers can lead to increased phage resistance. The findings suggest that CRISPR1 is a novel and effective phage resistance system in S. thermophilus.CRISPR-mediated phage resistance in Streptococcus thermophilus is a novel defense mechanism that allows bacteria to acquire resistance against bacteriophages. This system involves the integration of short stretches of phage-derived sequences (spacers) into CRISPR loci, which are then used to recognize and neutralize phage infections. In this study, researchers characterized the efficiency of CRISPR1 as a phage resistance mechanism in S. thermophilus. They found that CRISPR1 is distinct from previously known phage defense systems and is effective against the two main groups of S. thermophilus phages. The addition of new spacers in CRISPR1 increases the overall phage resistance of the host. The new spacers are typically 29 to 31 nucleotides long, with 30 being the most common. Comparative analysis of these spacers with the genomes of wild-type phages showed that the newly added spacer must be identical to a region (named proto-spacer) in the phage genome to confer resistance. Additionally, a specific sequence (NNAGAAW) located downstream of the proto-spacer region is important for the phage resistance phenotype. The study also showed that virulent phages rapidly evolve through single nucleotide mutations or deletions in response to CRISPR1. S. thermophilus is an important industrial lactic acid bacterium used in dairy production, but its use has been hindered by the presence of virulent phages. The study highlights the role of CRISPR1 in phage-host interactions and demonstrates that iterative addition of spacers can lead to increased phage resistance. The findings suggest that CRISPR1 is a novel and effective phage resistance system in S. thermophilus.